{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:06:19Z","timestamp":1760573179270,"version":"build-2065373602"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07197-5","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T15:51:08Z","timestamp":1760457068000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptome analysis of HPV16-positive cells expressing intrabodies targeting E6 and E7 oncoproteins to unravel intrabody antitumor activity"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3058-4647","authenticated-orcid":false,"given":"Susanna","family":"Falcucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8029-8625","authenticated-orcid":false,"given":"Sabrina","family":"Tait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5163-2698","authenticated-orcid":false,"given":"Maria Vincenza","family":"Chiantore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3791-3781","authenticated-orcid":false,"given":"Anna Rita","family":"Ciccaglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9619-0838","authenticated-orcid":false,"given":"Carla","family":"Amici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4737-374X","authenticated-orcid":false,"given":"Paola","family":"Di Bonito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5091-9272","authenticated-orcid":false,"given":"Luisa","family":"Accardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"7197_CR1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C de Martel","year":"2017","unstructured":"de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141:664\u201370.","journal-title":"Int J Cancer"},{"key":"7197_CR2","doi-asserted-by":"publisher","unstructured":"de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Heal [Internet]. 2020;8:e180\u201390. Available from: https:\/\/doi.org\/10.1016\/S2214-109X(19)30488-7.","DOI":"10.1016\/S2214-109X(19)30488-7"},{"key":"7197_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines10091543","volume":"10","author":"E Goodman","year":"2022","unstructured":"Goodman E, Reuschenbach M, Kaminski A, Ronnebaum S. Human papillomavirus vaccine impact and effectiveness in six High-Risk populations: A systematic literature review. Vaccines. 2022;10:1\u201316.","journal-title":"Vaccines"},{"key":"7197_CR4","doi-asserted-by":"publisher","unstructured":"Felsher M, Shumet M, Velicu C, Chen YT, Nowicka K, Marzec M et al. A systematic literature review of human papillomavirus vaccination strategies in delivery systems within national and regional immunization programs. Hum Vaccines Immunother [Internet]. 2024;20. Available from: https:\/\/doi.org\/10.1080\/21645515.2024.2319426.","DOI":"10.1080\/21645515.2024.2319426"},{"key":"7197_CR5","doi-asserted-by":"crossref","unstructured":"Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, Ghissassi F, El et al. A review of human carcinogens\u2014Part B: biological agents. Lancet Oncol [Internet]. 2009;10:321\u20132. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470204509700968.","DOI":"10.1016\/S1470-2045(09)70096-8"},{"key":"7197_CR6","doi-asserted-by":"crossref","unstructured":"Amici C, Visintin M, Verachi F, Paolini F, Percario Z, Bonito P, Di et al. A novel intracellular antibody against the E6 oncoprotein impairs growth of human papillomavirus 16-positive tumor cells in mouse models. Oncotarget [Internet]. 2016;7:15539\u201353. Available from: http:\/\/www.oncotarget.com\/fulltext\/6925.","DOI":"10.18632\/oncotarget.6925"},{"key":"7197_CR7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ijc.21052","volume":"116","author":"L Accardi","year":"2005","unstructured":"Accardi L, Don\u00e0 MG. Intracellular anti-E7 human antibodies in single-chain format inhibit proliferation of HPV16-positive cervical carcinoma cells. Int J Cancer. 2005;116:564\u201370.","journal-title":"Int J Cancer"},{"key":"7197_CR8","doi-asserted-by":"publisher","unstructured":"Vats A, Trejo-Cerro O, Thomas M, Banks L. Human papillomavirus E6 and E7: What remains? Tumour Virus Res [Internet]. 2021;11:200213. Available from: https:\/\/doi.org\/10.1016\/j.tvr.2021.200213.","DOI":"10.1016\/j.tvr.2021.200213"},{"key":"7197_CR9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0378-1119(96)00628-2","volume":"187","author":"L Persic","year":"1997","unstructured":"Persic L, Roberts A, Wilton J, Cattaneo A, Bradbury A, Hoogenboom HR. An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries. Gene. 1997;187:9\u201318.","journal-title":"Gene"},{"key":"7197_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-01841-w","volume":"40","author":"F Paolini","year":"2021","unstructured":"Paolini F, Amici C, Carosi M, Bonomo C, Di Bonito P, Venuti A, et al. Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors. J Exp Clin Cancer Res. 2021;40:1\u201311.","journal-title":"J Exp Clin Cancer Res"},{"key":"7197_CR11","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1002\/ijc.28604","volume":"134","author":"L Accardi","year":"2014","unstructured":"Accardi L, Paolini F, Mandarino A, Percario Z, Di Bonito P, Di Carlo V, et al. In vivo antitumor effect of an intracellular single-chain antibody fragment against the E7 oncoprotein of human papillomavirus 16. Int J Cancer. 2014;134:2742\u20137.","journal-title":"Int J Cancer"},{"key":"7197_CR12","doi-asserted-by":"publisher","unstructured":"Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Publ Gr [Internet]. 2010;10:550\u201360. Available from: https:\/\/doi.org\/10.1038\/nrc2886.","DOI":"10.1038\/nrc2886"},{"key":"7197_CR13","doi-asserted-by":"crossref","unstructured":"Accardi L, Don\u00e0 MG, Mileo AM, Paggi MG, Federico A, Torreri P et al. Retinoblastoma-independent antiproliferative activity of novel intracellular antibodies against the E7 oncoprotein in HPV 16-positive cells. BMC Cancer. 2011;11.","DOI":"10.1186\/1471-2407-11-17"},{"key":"7197_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-7-1","volume":"7","author":"MG Don\u00e0","year":"2007","unstructured":"Don\u00e0 MG, Giorgi C, Accardi L. Characterization of antibodies in single-chain format against the E7 oncoprotein of the human papillomavirus type 16 and their improvement by mutagenesis. BMC Cancer. 2007;7:1\u201314.","journal-title":"BMC Cancer"},{"key":"7197_CR15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u2206\u2206CT method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"7197_CR16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10719-023-10134-7","volume":"40","author":"H Wang","year":"2023","unstructured":"Wang H, Luo S, Wu X, Ruan Y, Qiu L, Feng H, et al. Exploration of glycosyltransferases mutation status in cervical cancer reveals PARP14 as a potential prognostic marker. Glycoconj J. 2023;40:513\u201322.","journal-title":"Glycoconj J"},{"key":"7197_CR17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/gyno.1998.5195","volume":"71","author":"JW Kim","year":"1998","unstructured":"Kim JW, Kim SJ, Han SM, Paik SY, Hur SY, Kim YW, et al. Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human cervical cancers. Gynecol Oncol. 1998;71:266\u20139.","journal-title":"Gynecol Oncol"},{"key":"7197_CR18","doi-asserted-by":"publisher","unstructured":"Su WY, Li JT, Cui Y, Hong J, Du W, Wang YC et al. Bidirectional regulation between WDR83 and its natural antisense transcript DHPS in gastric cancer. Cell Res [Internet]. 2012;22:1374\u201389. Available from: https:\/\/doi.org\/10.1038\/cr.2012.57.","DOI":"10.1038\/cr.2012.57"},{"key":"7197_CR19","doi-asserted-by":"crossref","first-page":"A174","DOI":"10.1136\/esmoopen-2018-EACR25.415","volume":"3","author":"E Mart\u00edn-S\u00e1nchez","year":"2018","unstructured":"Mart\u00edn-S\u00e1nchez E, Guarch R, Blanco-Luquin I, Mendaza S, Ulazia-Garmendia A, Monreal-Santesteban I, et al. PO-388 epigenetic Silencing of ZNF177 by MIR-877\u20133 p could be involved in cervical cancer progression. ESMO Open. 2018;3:A174.","journal-title":"ESMO Open"},{"key":"7197_CR20","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Ram\u00edrez I, Carrillo-Garc\u00eda A, Contreras-Paredes A, Ortiz-S\u00e1nchez E, Cruz-Gregorio A, Lizano M. Regulation of cellular metabolism by high-risk human papillomaviruses. Int J Mol Sci. 2018;19.","DOI":"10.3390\/ijms19071839"},{"key":"7197_CR21","doi-asserted-by":"publisher","unstructured":"Sitarz K, Czamara K, Szostek S, Kaczor A. The impact of HPV infection on human glycogen and lipid metabolism \u2013 a review. Biochim Biophys Acta - Rev Cancer [Internet]. 2022;1877:188646. Available from: https:\/\/doi.org\/10.1016\/j.bbcan.2021.188646.","DOI":"10.1016\/j.bbcan.2021.188646"},{"key":"7197_CR22","first-page":"312","volume":"6","author":"R Zhang","year":"2016","unstructured":"Zhang R, Su J, Xue SL, Yang H, Ju LL, Ji Y, et al. HPV E6\/p53 mediated down-regulation of miR-34a inhibits Warburg effect through targeting LDHA in cervical cancer. Am J Cancer Res. 2016;6:312\u201320.","journal-title":"Am J Cancer Res"},{"key":"7197_CR23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","volume":"5","author":"GN Masoud","year":"2015","unstructured":"Masoud GN, Li W. HIF-1\u03b1 pathway: Role, regulation and intervention for cancer therapy. Acta Pharm Sin B. 2015;5:378\u201389.","journal-title":"Acta Pharm Sin B"},{"key":"7197_CR24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/pro.3978","volume":"30","author":"R Oughtred","year":"2021","unstructured":"Oughtred R, Rust J, Chang C, Breitkreutz BJ, Stark C, Willems A, et al. The biogrid database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions. Protein Sci. 2021;30:187\u2013200.","journal-title":"Protein Sci"},{"key":"7197_CR25","doi-asserted-by":"publisher","unstructured":"Goldberg MW. Nuclear pore complex tethers to the cytoskeleton. Semin Cell Dev Biol [Internet]. 2017;68:52\u20138. Available from: https:\/\/doi.org\/10.1016\/j.semcdb.2017.06.017.","DOI":"10.1016\/j.semcdb.2017.06.017"},{"key":"7197_CR26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrm.2015.7","volume":"17","author":"H Hir","year":"2016","unstructured":"Hir H, Le, Sauli\u00e8re J, Wang Z. The exon junction complex as a node of post-transcriptional networks. Nat Rev Mol Cell Biol. 2016;17:41\u201354.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7197_CR27","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.2174\/1381612824666180711122753","volume":"24","author":"R Gundamaraju","year":"2018","unstructured":"Gundamaraju R, Vemuri R, Chong WC, Geraghty DP, Eri R. Cell stress signaling cascades regulating cell fate. Curr Pharm Des. 2018;24:3176\u201383.","journal-title":"Curr Pharm Des"},{"key":"7197_CR28","doi-asserted-by":"publisher","unstructured":"Zhang W, Shi Y, Oyang L, Cui S, Li S, Li J et al. Endoplasmic reticulum stress\u2014a key guardian in cancer. Cell Death Discov [Internet]. 2024;10:1\u201316. Available from: https:\/\/doi.org\/10.1038\/s41420-024-02110-3.","DOI":"10.1038\/s41420-024-02110-3"},{"key":"7197_CR29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.semcdb.2023.08.002","volume":"156","author":"R Kandel","year":"2024","unstructured":"Kandel R, Jung J, Neal S. Proteotoxic stress and the ubiquitin proteasome system. Semin Cell Dev Biol. 2024;156:107\u201320.","journal-title":"Semin Cell Dev Biol"},{"key":"7197_CR30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrclinonc.2016.206","volume":"14","author":"EE Manasanch","year":"2017","unstructured":"Manasanch EE, Orlowski RZ. Proteasome inhibitors in cancer therapy. Nat Rev Clin Oncol. 2017;14:417\u201333.","journal-title":"Nat Rev Clin Oncol"},{"key":"7197_CR31","doi-asserted-by":"publisher","unstructured":"Gonzalez-Meljem JM, Apps JR, Fraser HC, Martinez-Barbera JP. Paracrine roles of cellular senescence in promoting tumourigenesis. Br J Cancer [Internet]. 2018;118:1283\u20138. Available from: https:\/\/doi.org\/10.1038\/s41416-018-0066-1.","DOI":"10.1038\/s41416-018-0066-1"},{"key":"7197_CR32","doi-asserted-by":"publisher","unstructured":"Yuan Y, Cai X, Shen F, Ma F. HPV post-infection microenvironment and cervical cancer. Cancer Lett [Internet]. 2021;497:243\u201354. Available from: https:\/\/doi.org\/10.1016\/j.canlet.2020.10.034.","DOI":"10.1016\/j.canlet.2020.10.034"},{"key":"7197_CR33","doi-asserted-by":"crossref","unstructured":"Morein D, Erlichman N, Ben-Baruch A. Beyond cell motility: the expanding roles of chemokines and their receptors in malignancy. Front Immunol. 2020;11.","DOI":"10.3389\/fimmu.2020.00952"},{"key":"7197_CR34","doi-asserted-by":"publisher","unstructured":"Kong W, Zhao G, Chen H, Wang W, Shang X, Sun Q et al. Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironment. Cancer Cell Int [Internet]. 2021;21:1\u201315. Available from: https:\/\/doi.org\/10.1186\/s12935-021-02101-9.","DOI":"10.1186\/s12935-021-02101-9"},{"key":"7197_CR35","doi-asserted-by":"crossref","unstructured":"Fernandez-Avila L, Castro-Amaya AM, Molina-Pineda A, Hern\u00e1ndez-Guti\u00e9rrez R, Jave-Suarez LF, Aguilar-Lemarroy A. The value of CXCL1, CXCL2, CXCL3, and CXCL8 as potential prognosis markers in cervical cancer: evidence of E6\/E7 from HPV16 and 18 in chemokines regulation. Biomedicines. 2023;11.","DOI":"10.3390\/biomedicines11102655"},{"key":"7197_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.68.1.1","volume":"68","author":"JA Belperio","year":"2000","unstructured":"Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Burdick MD, et al. CXC chemokines in angiogenesis. J Leukoc Biol. 2000;68:1\u20138.","journal-title":"J Leukoc Biol"},{"key":"7197_CR37","doi-asserted-by":"publisher","unstructured":"Billottet C, Quemener C, Bikfalvi A. CXCR3, a double-edged sword in tumor progression and angiogenesis. Biochim Biophys Acta - Rev Cancer [Internet]. 2013;1836:287\u201395. Available from: https:\/\/doi.org\/10.1016\/j.bbcan.2013.08.002.","DOI":"10.1016\/j.bbcan.2013.08.002"},{"key":"7197_CR38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1152\/ajpcell.00441.2005","volume":"291","author":"S Shahabuddin","year":"2006","unstructured":"Shahabuddin S, Ji R, Wang P, Brailoiu E, Dun N, Yang Y, et al. CXCR3 chemokine receptor-induced chemotaxis in human airway epithelial cells: role of p38 MAPK and PI3K signaling pathways. Am J Physiol - Cell Physiol. 2006;291:34\u20139.","journal-title":"Am J Physiol - Cell Physiol"},{"key":"7197_CR39","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1242\/jcs.042895","volume":"122","author":"VL Martins","year":"2009","unstructured":"Martins VL, Vyas JJ, Chen M, Purdie K, Mein CA, South AP, et al. Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen. J Cell Sci. 2009;122:1788\u201399.","journal-title":"J Cell Sci"},{"key":"7197_CR40","first-page":"1","volume":"11","author":"X Chen","year":"2021","unstructured":"Chen X, He H, Xiao Y, Hasim A, Yuan J, Ye M, et al. CXCL10 produced by HPV-Positive cervical cancer cells stimulates Exosomal PDL1 expression by fibroblasts via CXCR3 and JAK-STAT pathways. Front Oncol. 2021;11:1\u201314.","journal-title":"Front Oncol"},{"key":"7197_CR41","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1002\/cam4.934","volume":"5","author":"Q Ding","year":"2016","unstructured":"Ding Q, Lu P, Xia Y, Ding S, Fan Y, Li X, et al. CXCL9: evidence and contradictions for its role in tumor progression. Cancer Med. 2016;5:3246\u201359.","journal-title":"Cancer Med"},{"key":"7197_CR42","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/IGC.0000000000000153","volume":"24","author":"W Zhi","year":"2014","unstructured":"Zhi W, Ferris D, Sharma A, Purohit S, Santos C, He M, et al. Twelve serum proteins progressively increase with disease stage in squamous cell cervical cancer patients. Int J Gynecol Cancer. 2014;24:1085\u201392.","journal-title":"Int J Gynecol Cancer"},{"key":"7197_CR43","doi-asserted-by":"crossref","unstructured":"Zhao X, Liu J, Jin D, Ren C, Yang L, Zhu Y et al. EphA2 Promotes the development of cervical cancer through the CXCL11\/PD-L1 pathway. J Oncol. 2022;2022.","DOI":"10.1155\/2022\/4886907"},{"key":"7197_CR44","doi-asserted-by":"publisher","unstructured":"Yang X, Shen X, Li Z, Li W, Liu Y. Reduction in immune cell number and loss of 5hmC are associated with lesion grade in cervical carcinogenesis. 3 Biotech [Internet]. 2021;11:1\u20139. Available from: https:\/\/doi.org\/10.1007\/s13205-021-03028-8.","DOI":"10.1007\/s13205-021-03028-8"},{"key":"7197_CR45","first-page":"1957","volume":"23","author":"W Shen","year":"2019","unstructured":"Shen W, Xie XY, Liu MR, Wang LL. MicroRNA-101-5p inhibits the growth and metastasis of cervical cancer cell by inhibiting CXCL6. Eur Rev Med Pharmacol Sci. 2019;23:1957\u201368.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"7197_CR46","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nri887","volume":"2","author":"A Richmond","year":"2002","unstructured":"Richmond A. NF-\u03baB, chemokine gene transcription and tumour growth. Nat Rev Immunol. 2002;2:664\u201374.","journal-title":"Nat Rev Immunol"},{"key":"7197_CR47","doi-asserted-by":"publisher","unstructured":"Cabal-Hierro L, Rodr\u00edguez M, Artime N, Iglesias J, Ugarte L, Prado MA et al. TRAF-mediated modulation of NF-kB AND JNK activation by TNFR2. Cell Signal [Internet]. 2014;26:2658\u201366. Available from: https:\/\/doi.org\/10.1016\/j.cellsig.2014.08.011.","DOI":"10.1016\/j.cellsig.2014.08.011"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07197-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07197-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07197-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T02:11:35Z","timestamp":1760494295000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07197-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7197"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07197-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"type":"electronic","value":"1479-5876"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1095"}}